Caris & Co. downgrades Par Pharmaceutical Companies (NYSE: PRX) from Buy to Above Average.

This morning's downgrade ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE